Mu Qiao
Co-founder and Chief Technology Officer, Mizuki Molecule
Dr Qiao Mu is the co-founder and CTO of Waterwood Molecules. Incubated by Tsinghua University's Institute for Intelligent Industry Research, Mizuki Molecule is dedicated to building a fundamental big model of the biopharmaceutical industry and a new generation of conversational biopharmaceutical R&D assistant. Dr Qiao Mu previously worked at IBM Research - Almaden in Silicon Valley, USA, as a research leader in the AI platform department. He led a number of technology solutions that were successfully applied to IBM's core products and served Fortune 500 companies. Dr Qiao Mu's work has been recognised with a number of major awards including the IBM Outstanding Technical Achievement Award, Outstanding Research Achievement Award, and the IBM High Value Invention Patent Award. He holds more than 70 U.S. patents (over 40 granted) and has twice been named an IBM Master Inventor. He was inducted as a Member of IBM Academy of Technology in 2021. Dr Chomu was an IBM Global Quantum Ambassador. Dr Chomu was inducted into the US NAE Frontiers of Engineering Program in 2023 (81 in the US). He is also an Industrial Instructor in the Department of Computer Science at Stanford University. He has worked at eBay Research Labs, Xerox PARC, IBM T.J. Watson and other world-class research institutes. Joki received his Ph.D. in Computer Science and Engineering from Pennsylvania State University, USA in 2012.
Topic
Multimodal biomedical macromodelling and its industry applications
AI Big Models are bringing new changes to the development of the biopharmaceutical industry. From drug project evaluation, preclinical research, to all stages of clinical trials, big models can help pharmaceutical industry experts and improve the efficiency of drug development. Mizuki Molecules released the world's first commercially available multimodal biomedical 10 billion parameter big model, the first 100 billion parameter multimodal biomedical dialogue big model, and the new generation of dialogue drug development assistant ChatDD, which redefines the mode of drug R&D by combining the expert cognition and big model knowledge. This sharing will introduce the latest progress of multimodal biomedical big models and their practical applications in the industry.
